Norpace and Xalatan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Norpace (disopyramide phosphate) and Xalatan (latanoprost). Common drug interactions include cardiac failure congestive among females and adrenal insufficiency among males.

The phase IV clinical study analyzes what interactions people have when they take Norpace and Xalatan. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Norpace?

Norpace has active ingredients of disopyramide phosphate. eHealthMe is studying from 1,179 Norpace users. Check the latest studies of Norpace.

What is Xalatan?

Xalatan has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 25,550 Xalatan users. Check the latest studies of Xalatan.

On Jul, 06, 2026

12 people who take Norpace and Xalatan together, and have interactions are studied.

What are the common drug interactions of Norpace and Xalatan, by gender? *:

female:

Cardiac failure congestive
Diabetes mellitus inadequate control
Dyspnoea (difficult or laboured respiration)
Seasonal allergy (allergic condition due to certain season)
Wheezing (a high-pitched whistling sound made while you breath)
Alopecia (absence of hair from areas of the body)
Global amnesia (a temporary short-term memory loss)
Iliotibial band syndrome (injury to the thigh)
Malaise (a feeling of general discomfort or uneasiness)
Muscular weakness (muscle weakness)

male:

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Anaemia (lack of blood)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Depression
Disability
Dyspnoea (difficult or laboured respiration)
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Fall
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)

What are the common drug interactions of Norpace and Xalatan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Alopecia (absence of hair from areas of the body)

60+:

Global amnesia (a temporary short-term memory loss)
Iliotibial band syndrome (injury to the thigh)
Malaise (a feeling of general discomfort or uneasiness)
Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

Stress And Anxiety: 5 people, 41.67%
Metastases To Central Nervous System (cancer spreads to central nervous system): 5 people, 41.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 25.00%
Dizziness: 2 people, 16.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 16.67%
Asthma: 2 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Pain: 1 person, 8.33%
Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 1 person, 8.33%
Hypersensitivity: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Norpace and Xalatan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously